Abstract
Ulcers occur because of an imbalance between mucosal protective resistance and damaging luminal factors, allowing the latter to predominate. The primary injurious elements are acid and peptic activity. Bile reflux, drugs, and gastroduodenal stasis may alter the luminal milieu and act together with acid-peptic activity to produce injury, weaken mucosal resistance, or both. Since prostaglandins modulate several key mucosal protective mechanisms, and since some exogenous prostaglandins and their derivatives accelerate peptic ulcer healing, it seems plausible that prostaglandin deficiency may contribute to the development of peptic ulcers. At the present time, however, evidence for this postulate is mostly indirect and can be summarized as follows: (1) Defects of mucosal protective mechanisms modulated by prostaglandins have been found in different forms of ulcer disease. Such defects include impaired duodenal bicarbonate secretion, deficient secretion or accelerated degradation of mucus, and reduced mucosal cell proliferation. (2) Drugs that inhibit cyclooxygenase, the key enzyme in tissue prostaglandin synthesis, have ulcerogenic activity. Presumably, in this situation, reduced prostaglandin production renders the mucosa more vulnerable to the action of acid and pepsin, or reduces the capability of the mucosa to repair itself. (3) Decreased mucosal prostaglandin synthesis or prostaglandin content has been found in patients with ulcer disease. Several studies have provided quantitative evidence of disturbed prostaglandin metabolism in some forms of ulcer disease. These studies are of high interest, but they need to be interpreted with caution given the present scientific debate regarding the physiological role of different prostanoids, as well as uncertainty as to the specific cellular source of prostaglandins in gastroduodenal mucosa.
Similar content being viewed by others
References
Robert A: Role of endogenous and exogenous prostaglandins in mucosal protection.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemstrom, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 377–382
Tashjian AH Jr, Voelkel EF, Robinson DR, Levine L: Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma. J Clin Invest 74:2042–2048, 1984
Lee TH, Mencia-Huerta J-M, Shih C, Corey EJ, Lewis RA, Austen KF: Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74:1922–1933, 1984
Johansson C, Bergstrom S: Prostaglandins and protection of the gastroduodenal mucosa. Scand J Gastroenterol (Suppl 77):21–46, 1982
Ahlquist DA, Duenes JA, Madson TH, Romero JC, Dozois RR, Malagelada J-R: Prostaglandin generation from gastroduodenal mucosa: Regional and species differences. Prostaglandins 24:115–125, 1982
Levine RA, Schwartzel EH: Effect of indomethacin on basal and histamine stimulated human gastric acid secretion. Gut 25:718–722, 1984
Sharon P, Cohen F, Zifroni A, Karmeli F, Ligumsky M, Rachmilewitz D: Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer. Scand J Gastroenterol 18:1045–1049, 1983
Konturek SJ, Kwiecien N, Obtulowicz W, Oleksy J, Sito E, Kopp B: Prostaglandins in peptic ulcer disease: Effect of nonsteroidal antiinflammatory compounds (NOSAC), Scand J Gastroenterol 19(Suppl 92):250–254, 1984
Ahlquist DA, Madson TH, Romero JC, Dozois RR, Malagelada J-R: Factors influencing metabolism of arachidonic acid in guinea pig gastric mucosa. Am J Physiol 244:G131-G137, 1983
Ahlquist DA, Dozois RR, Zinsmeister AR, Malagelada J-R: Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. Gastroenterology 85:522–528, 1983
Szabo S: Biology of disease. Pathogenesis of duodenal ulcer disease. Lab Invest 51:121–147, 1984
Briden S, Flemstrom G, Kivilaakso F: Effects of cysteamine on the duodenal mucosal alkaline response to luminal acid.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemstrom, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 189–194
Domschke W, Domschke S, Hagel J, Demling L, Croft DN: Gastric epithelial cell turnover, mucus production, and healing of gastric ulcers with carbenoxolone. Gut 18:817–820, 1977
Parke DV, Symons AM: The biochemical pharmacology of mucus.In Mucus in Health and Disease. M Elstein, DV Parke (eds). New York, Plenum Press, 1977, pp 423–441
Miller LJ, Malagelada J-R, Longstreth GF, Go VLW: Dysfunctions of the stomach with gastric ulceration. Dig Dis Sci 25:857–864, 1980
Rees WDW, Warhurst G, Turnberg LA: Studies of bicarbonate secretion by the normal human stomachin vivo: Effect of sodium taurocholate and aspirin. Gastroenterology 82:1158, 1982 (abstract)
Basso N, Materia A, Forlini A, Jaffe BM: Prostaglandin generation in the gastric mucosa of rats with stress ulcer. Surgery 94:104–108, 1983
Wright JP, Young GO, Klaff LJ, Weers LA, Price SK, Marks IN: Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma. Gastroenterology 82:263–267, 1982
Moore SC, Shorter RG, Barham SS, Duenes JA, Zinsmeister AR, Malagelada J-R: Interrelationships among gastric mucosal morphology and prostaglandin (PG) synthesis, luminal pH, and motility in ulcer disease. Gastroenterology 86:1188, 1984 (abstract)
Whittle BJ, Vane JR: A biochemical basis for the gastrointestinal toxicity of nonsteroid antirheumatoid drugs. Arch Toxicol 7(Suppl):315–322, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malagelada, JR., Ahlquist, D.A. & Moore, S.C. Defects in prostaglandin synthesis and metabolism in ulcer disease. Digest Dis Sci 31 (Suppl 2), 20S–27S (1986). https://doi.org/10.1007/BF01309318
Issue Date:
DOI: https://doi.org/10.1007/BF01309318